Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Operating Expenses: 2018-2024

Historic Operating Expenses for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to $413.4 million.

  • Legend Biotech's Operating Expenses fell 13.03% to -$147.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$412.3 million, marking a year-over-year decrease of 0.11%. This contributed to the annual value of $413.4 million for FY2024, which is 8.19% up from last year.
  • According to the latest figures from FY2024, Legend Biotech's Operating Expenses is $413.4 million, which was up 8.19% from $382.1 million recorded in FY2023.
  • Legend Biotech's 5-year Operating Expenses high stood at $413.4 million for FY2024, and its period low was $210.4 million during FY2020.
  • Its 3-year average for Operating Expenses is $350.2 million, with a median of $382.1 million in 2023.
  • Its Operating Expenses has fluctuated over the past 5 years, first fell by 4.27% in 2022, then skyrocketed by 49.84% in 2023.
  • Yearly analysis of 5 years shows Legend Biotech's Operating Expenses stood at $210.4 million in 2020, then grew by 26.59% to $266.4 million in 2021, then decreased by 4.27% to $255.0 million in 2022, then skyrocketed by 49.84% to $382.1 million in 2023, then rose by 8.19% to $413.4 million in 2024.